Rena Fox, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address1545 Divisadero Street
San Francisco CA 94115
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Stanford UniversityB.A.1991Human Biology
    Bryn Mawr CollegePost-Baccalaureate1992
    University of California San DiegoM.D.1997School of Medicine
    University of WashingtonInternship and Residency2000Internal Medicine
    UCSFClinician-Educator Fellowship2001General Internal Medicine
    University of California, San Francisco, CA2018Diversity, Equity, and Inclusion Champion Training
    Collapse Awards and Honors
    UCSF2019UCSF Health Team PRIDE Award Winner for UCSF HCV Project ECHO
    UCSF Academy of Medical Educators2013Excellence in Teaching Award, The Haile T. Debas Academy of Medical Educators
    UCSF Division of General Internal Medicine2010Robert H. Crede Award for Clinical Care
    EASL (European Association for the Study of the Liver)2008Top 10% Research Poster
    AASLD2003The Jan Albrecht Commitment to Clinical Research in Liver Diseases Award
    University of Washington2000Outstanding Resident of the Year, Department of Medicine

    Collapse Overview 
    Collapse Overview
    Dr. Rena Fox is a Professor of Medicine at University of California, San Francisco (UCSF). She has been on the faculty in the Division of General Internal Medicine for 19 years. Dr. Fox was an undergraduate at Stanford, got her MD at UC San Diego and did her internal medicine residency at University of Washington. She was a general medicine fellow at UCSF with an interest in hepatitis C during which time she was trained by UCSF hepatologists in viral hepatitis and since then, Dr. Fox has been the sole faculty member at UCSF who is both an expert in hepatitis C and is a general internist, and is one of the few people in the country in this unique position. Dr. Fox is internationally recognized as an educator – she lectures around the country and she has been working with the Veterans Administration for a decade on hepatitis C educational tools, national policies, as the Medical Editor of the VA Viral Hepatitis Website and in research. As part of the DHHS Hepatitis Action Plan, and the CDC aim to educate the country’s physicians in hepatitis C, she served as an editor for online hepatitis C curriculum for HCV education. She is a co-author and panel member of the clinical practice guidelines for the VA regarding the use of hepatitis C drugs. She served as a clinical expert for the California Technology Assessment Forum (CTAF) meetings on hepatitis C drugs in 2014 and is currently a CTAF voting panel member and Vice Chair. She serves on the faculty of the UCSF Hepatitis C ECHO clinic, providing telemedicine consultation on hepatitis C management for providers in underserved and rural areas. As a researcher, she studies hepatitis C epidemiology and clinical outcomes, including long term outcomes of hepatocellular carcinoma and cirrhosis in large multicenter studies. Most recently, Dr. Fox has begun to conduct research on fatty liver disease and ways to identify patients with fatty liver disease in primary care before they develop advanced liver damage. Dr. Fox trains UCSF medical students and Internal Medicine residents. She sees patients in two settings – she has a large panel of primary care patients at the UCSF General Medicine practice, and she treats hepatitis C patients at the Liver Clinic at UCSF.

    Collapse Research 
    Collapse Research Activities and Funding
    Implementation of an Electronic Medical Record Algorithm to Identify and Refer Patients at High Risk of NASH from Primary Care
    Gilead Sciences IN-US-989-5737Jul 1, 2020 - Dec 31, 2022
    Role: PI
    SF CAN Liver Cancer Task Force
    SF CAN - The San Francisco Cancer Initiative Jul 1, 2019
    Role: PI

    Collapse ORNG Applications 
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hepatitis C Virus Cure and Obesity: Watch the Weight. J Gen Intern Med. 2020 10; 35(10):2836-2837. Mukhtar NA, Fox RK. PMID: 32632793.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. Cancer health disparities in racial/ethnic minorities in the United States. Br J Cancer. 2021 01; 124(2):315-332. Zavala VA, Bracci PM, Carethers JM, Carvajal-Carmona L, Coggins NB, Cruz-Correa MR, Davis M, de Smith AJ, Dutil J, Figueiredo JC, Fox R, Graves KD, Gomez SL, Llera A, Neuhausen SL, Newman L, Nguyen T, Palmer JR, Palmer NR, Pérez-Stable EJ, Piawah S, Rodriquez EJ, Sanabria-Salas MC, Schmit SL, Serrano-Gomez SJ, Stern MC, Weitzel J, Yang JJ, Zabaleta J, Ziv E, Fejerman L. PMID: 32901135.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    3. Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs. PLoS One. 2019; 14(6):e0217471. Coffin PO, Santos GM, Behar E, Hern J, Walker J, Matheson T, Kinnard EN, Silvis J, Vittinghoff E, Fox R, Page K. PMID: 31158245.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    4. Aspirin Use and Risk of Hepatocellular Carcinoma in Hepatitis B. JAMA Intern Med. 2019 05 01; 179(5):640-641. Fox RK, Taddei TH, Kaplan DE. PMID: 30882884.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Healthcare Costs Related to Treatment of Hepatocellular Carcinoma Among Veterans With Cirrhosis in the United States. Clin Gastroenterol Hepatol. 2018 Jan; 16(1):106-114.e5. Kaplan DE, Chapko MK, Mehta R, Dai F, Skanderson M, Aytaman A, Baytarian M, D'Addeo K, Fox R, Hunt K, Pocha C, Valderrama A, Taddei TH, VOCAL Study Group . PMID: 28756056.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    6. Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality. Gastroenterology. 2017 06; 152(8):1954-1964. Serper M, Taddei TH, Mehta R, D'Addeo K, Dai F, Aytaman A, Baytarian M, Fox R, Hunt K, Goldberg DS, Valderrama A, Kaplan DE, VOCAL Study Group . PMID: 28283421.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    7. Going Viral: Why Eliminating the Burden of Hepatitis C Requires Enhanced Cooperation Between Specialists and Primary Care Providers. Dig Dis Sci. 2016 12; 61(12):3381-3383. Fox R. PMID: 27619392.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    8. Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis. Hepatology. 2017 03; 65(3):864-874. Goldberg DS, Taddei TH, Serper M, Mehta R, Dieperink E, Aytaman A, Baytarian M, Fox R, Hunt K, Pedrosa M, Pocha C, Valderrama A, Kaplan DE. PMID: 27531119.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansPHPublic Health
    9. Recalibrating the Child-Turcotte-Pugh Score to Improve Prediction of Transplant-Free Survival in Patients with Cirrhosis. Dig Dis Sci. 2016 11; 61(11):3309-3320. Kaplan DE, Dai F, Skanderson M, Aytaman A, Baytarian M, D'Addeo K, Fox R, Hunt K, Knott A, Mehta R, Pedrosa M, Pocha C, Valderrama A, Taddei T, VOCAL Study Group . PMID: 27405990.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    10. Pharmacologic Therapies in Gastrointestinal Diseases. Med Clin North Am. 2016 Jul; 100(4):827-50. Fox RK, Muniraj T. PMID: 27235617.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    11. Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population. JAMA Intern Med. 2016 Jan; 176(1):65-73. Chahal HS, Marseille EA, Tice JA, Pearson SD, Ollendorf DA, Fox RK, Kahn JG. PMID: 26595724.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    12. Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database. Clin Gastroenterol Hepatol. 2015 Dec; 13(13):2333-41.e1-6. Kaplan DE, Dai F, Aytaman A, Baytarian M, Fox R, Hunt K, Knott A, Pedrosa M, Pocha C, Mehta R, Duggal M, Skanderson M, Valderrama A, Taddei TH, VOCAL Study Group . PMID: 26188137.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    13. Toward the Effective Co-management of Patients with Cirrhosis by Primary Care Providers and Specialists. Dig Dis Sci. 2015 Sep; 60(9):2576-8. Fox RK. PMID: 25986522.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. The State of Hepatitis C Care in the VA. Fed Pract. 2015 Feb; 32(Suppl 2):20S-24S. Belperio PS, Fox RK, Backus LI. PMID: 30766108.
      View in: PubMed   Mentions:
    15. Falsely Decreased HbA1c in a Type 2 Diabetic Patient Treated with Dapsone. Endocr Pract. 2014 Nov; 20(11):e229-32. Shah AD, Fox RK, Rushakoff RJ. PMID: 25100400.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. When to consider liver transplant during the management of chronic liver disease. Med Clin North Am. 2014 Jan; 98(1):153-68. Fox RK. PMID: 24266919.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    17. Hepatitis B--more treatments, more testing, not enough data. J Gen Intern Med. 2011 Mar; 26(3):232-3. Fox RK. PMID: 21267669.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. J Hepatol. 2007 Oct; 47(4):527-37. Bräu N, Fox RK, Xiao P, Marks K, Naqvi Z, Taylor LE, Trikha A, Sherman M, Sulkowski MS, Dieterich DT, Rigsby MO, Wright TL, Hernandez MD, Jain MK, Khatri GK, Sterling RK, Bonacini M, Martyn CA, Aytaman A, Llovet JM, Brown ST, Bini EJ, North American Liver Cancer in HIV Study Group . PMID: 17692986.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    19. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis. 2005 Jul 15; 41(2):177-86. Fox RK, Currie SL, Evans J, Wright TL, Tobler L, Phelps B, Busch MP, Page-Shafer KA. PMID: 15983913.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    20. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med. 2002 Apr 04; 346(14):1091-2. Seligman HK, Fox RK. PMID: 11936120.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    Rena's Networks
    Concepts (131)
    Derived automatically from this person's publications.
    Co-Authors (17)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department